EGFR and non-small cell lung carcinoma: The outcomes from the Western blotting analysis indicated a marked elevation in HRS levels upon either EGFR mutation or EGF stimulation in NSCLC cells, whereas levels of RAB27a and ALIX remained unchanged (Figure 2H and Figure S4A–D).